Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “breast cancer”

Feasibility of 'Exercise for CAncer Patients and Healthy EAting Timeframes' .Not Yet Recruiting
NCT07529353NAUpdated Aug 17, 2026
Sponsor: University of Rochester
Breast Cancer · Cancer Related Fatigue
United States
Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI)Recruiting
NCT04861077EARLY_Phase 1Updated Aug 17, 2026
Sponsor: University of Alabama at Birmingham
Triple Negative Breast Cancer
United States
Telemedicine-mHealth Symptom Cluster Intervention for Advanced Cancer Patients: Finding Our Center Under Stress (FOCUS)Suspended
NCT07102212NAUpdated Aug 17, 2026
Sponsor: Ohio State University Comprehensive Cancer Center
Lung Cancer · Breast Cancer · Prostate Cancer · Multiple Myeloma
United States
A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin AmericaCompleted
NCT04158258N/AUpdated Aug 17, 2026
Sponsor: Hoffmann-La Roche
Breast Cancer
Argentina, Brazil, Chile, Colombia, Cuba +5 more
An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of RuxolitinibActive Not Recruiting
NCT02955940Phase 2Updated Aug 17, 2026
Sponsor: Incyte Corporation
Pancreatic Cancer · Colorectal Cancer (CRC) · Breast Cancer · Lung Cancer
United States, Poland
Semaglutide and Structured Lifestyle Support to Improve Heart and Blood Vessel Health in Postmenopausal Obese Breast Cancer Survivors Taking Aromatase InhibitorsNot Yet Recruiting
NCT07769047Phase 4Updated Aug 17, 2026
Sponsor: Mayo Clinic
Anatomic Stage I Breast Cancer AJCC v8 · Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage III Breast Cancer AJCC v8
United States
Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can...Active Not Recruiting
NCT02484404Phase 1, Phase 2Updated Aug 17, 2026
Sponsor: National Cancer Institute (NCI)
Colorectal Neoplasms · Breast Neoplasms
United States
Identification of Early Markers of Response and Resistance to TrastuzumabCompleted
NCT01834950NAUpdated Aug 17, 2026
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer
France
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.Recruiting
NCT06072612Phase 3Updated Aug 17, 2026
Sponsor: BriaCell Therapeutics Corporation
Breast Cancer · Metastatic Breast Cancer · Breast Neoplasm · Breast Cancer Metastatic
United States
Genomic Services Research ProgramRecruiting
NCT02595957N/AUpdated Aug 17, 2026
Sponsor: National Human Genome Research Institute (NHGRI)
Colon Cancer · Breast Cancer
United States
Tucatinib Continuation StudyNot Yet Recruiting
NCT07768358Phase 4Updated Aug 17, 2026
Sponsor: Pfizer
HER2-positive Breast Cancer · Cervical Cancer · Biliary Tract Neoplasms · Urothelial Cancer
A PoC Study to Evaluate Treatments' Efficacy by Monitoring MRD Using ctDNA in HR-positive/HER2-negative EBC PopulationRecruiting
NCT05708235Phase 2Updated Aug 17, 2026
Sponsor: MedSIR
Breast Cancer
Spain, United Kingdom
A Study to Evaluate ATX-898 in Participants With Advanced Solid TumorsNot Yet Recruiting
NCT07767474Phase 1, Phase 2Updated Aug 17, 2026
Sponsor: Antares Therapeutics, Inc
Advanced Solid Tumors
A Study of Evaluating The Effects Of Pyrotinib After Adjuvant Trastuzumab In Women With Early Stage Breast CancerActive Not Recruiting
NCT03980054Phase 3Updated Aug 17, 2026
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Breast Cancer
China
Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast CancerActive Not Recruiting
NCT05340673Phase 1Updated Aug 17, 2026
Sponsor: City of Hope Medical Center
Breast Ductal Carcinoma In Situ · Invasive Breast Carcinoma
United States
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid TumorsRecruiting
NCT07360314Phase 1Updated Aug 17, 2026
Sponsor: EMD Serono Research & Development Institute, Inc.
Advanced Solid Tumors
United States, Canada, Japan, Spain
Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null PhenotypeRecruiting
NCT07341867Phase 1Updated Aug 17, 2026
Sponsor: Andrew Hantel, MD
Multiple Myeloma · Triple Negative Breast Cancer · Duffy Blood Group, Chemokine Receptor Gene Mutation · Duffy Blood Group, Chemokine Receptor Gene C.-67T>C
United States
Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKKRecruiting
NCT06358573Phase 2Updated Aug 17, 2026
Sponsor: Swiss Cancer Institute
Triple-negative Breast Cancer · TNBC - Triple-Negative Breast Cancer
France, Switzerland
Real-world Study of Trastuzumab Deruxtecan in Patients With Unresectable or Metastatic HER2-low Breast CancerRecruiting
NCT06727227N/AUpdated Aug 17, 2026
Sponsor: AstraZeneca
Breast Cancer
Bulgaria, Slovenia
Tai Chi for Reducing Aromatase Inhibitor-Induced ArthralgiaRecruiting
NCT07737951NAUpdated Aug 14, 2026
Sponsor: Thomas Jefferson University
Hormone Receptor Positive Breast Carcinoma · Postmenopausal · Breast Cancer
United States
Mobile Health Patient Navigation for the Improvement of Screening and the Early Detection of Breast Cancer in Women Accessing Primary Care Clinics in KenyaRecruiting
NCT07764796NAUpdated Aug 14, 2026
Sponsor: Emory University
Breast Carcinoma
United States
A Navigation Program to Improve Survivorship Support Service Participation Among Non-metastatic Breast Cancer SurvivorsRecruiting
NCT07699991NAUpdated Aug 14, 2026
Sponsor: Ohio State University Comprehensive Cancer Center
Anatomic Stage 0 Breast Cancer AJCC v8 · Anatomic Stage I Breast Cancer AJCC v8 · Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage III Breast Cancer AJCC v8
United States
Ovarian Cancer Liquid Biopsy for Early Assessment & Detection in Individuals With BRCA1/2 Pathogenic VariantsNot Yet Recruiting
NCT07764744NAUpdated Aug 14, 2026
Sponsor: Weill Medical College of Cornell University
Ovarian Neoplasms · BRCA 1 Gene Mutation · BRCA 2 Gene Mutation · Serous Tubal Intraepithelial Carcinoma
United States
Trastuzumab Rezetecan Followed by Pyrotinib, and Trastuzumab Combined With Capecitabine as First-line Treatment for Advanced HER2-positive Breast CancerNot Yet Recruiting
NCT07766772Phase 2Updated Aug 14, 2026
Sponsor: Fujian Cancer Hospital
HER2 + Breast Cancer · Advanced Breast Cancer
China
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)Recruiting
NCT06312176Phase 3Updated Aug 14, 2026
Sponsor: Merck Sharp & Dohme LLC
Breast Neoplasms
United States, Argentina, Australia, Belgium, Brazil +35 more

Previous page Next page